[HTML][HTML] Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer?
YS Li, HC Ren, JH Cao - International journal of …, 2022 - spandidos-publications.com
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is highly infectious and
pathogenic. Among patients with severe SARS‑CoV‑2‑caused by corona virus disease 2019 …
pathogenic. Among patients with severe SARS‑CoV‑2‑caused by corona virus disease 2019 …
Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a scoping review
AS Carvalho, Ó Brito Fernandes, M de Lange… - BMC health services …, 2022 - Springer
Background Cancer comprises a high burden on health systems. Performance indicators
monitoring cancer outcomes are routinely used in OECD countries. However, the …
monitoring cancer outcomes are routinely used in OECD countries. However, the …
[HTML][HTML] Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis
E de Azambuja, M Brandão, H Wildiers, A Laenen… - ESMO open, 2020 - Elsevier
Background Cancer seems to have an independent adverse prognostic effect on COVID-19-
related mortality, but uncertainty exists regarding its effect across different patient subgroups …
related mortality, but uncertainty exists regarding its effect across different patient subgroups …
[HTML][HTML] First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among experts
S Aeppli, M Schmaus, T Eisen, B Escudier, V Grünwald… - ESMO open, 2021 - Elsevier
Background The treatment landscape of metastatic clear cell renal cell carcinoma (mccRCC)
has been transformed by targeted therapies with tyrosine kinase inhibitors (TKI) and more …
has been transformed by targeted therapies with tyrosine kinase inhibitors (TKI) and more …
[HTML][HTML] SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic
T Fuereder, AS Berghoff, G Heller, H Haslacher… - ESMO open, 2020 - Elsevier
Background During the COVID-19 outbreak, healthcare professionals (HCP) are at the
frontline of clinical management and at increased risk for infection. The SARS-CoV-2 …
frontline of clinical management and at increased risk for infection. The SARS-CoV-2 …
Reviewing treatment options for advanced renal cell carcinoma: Is there still a place for tyrosine kinase inhibitor (TKI) monotherapy?
M Fontes-Sousa, H Magalhaes, A Oliveira… - Advances in …, 2022 - Springer
Renal cell carcinoma (RCC) comprises a highly heterogeneous group of kidney tumours
built upon distinct genetic-and epigenetic-driven mechanisms and molecular pathways …
built upon distinct genetic-and epigenetic-driven mechanisms and molecular pathways …
Immune checkpoint inhibitor (ICI) genes and aging in clear cell renal cell carcinoma (ccRCC): Clinical and genomic study
A Al-Danakh, M Safi, M Alradhi, Q Chen, S Baldi, X Zhu… - Cells, 2022 - mdpi.com
Background: It is anticipated that there will be a large rise in the number of tumor diagnoses
and mortality in those aged 65 and older over the course of upcoming decades. Immune …
and mortality in those aged 65 and older over the course of upcoming decades. Immune …
Immune checkpoint inhibitors use and effects on prognosis of COVID-19 infection: a systematic review and meta-analysis
W Qian, Y Ye, L Zuo, T Song, Q Xu, Y Wang… - …, 2021 - Taylor & Francis
Aim: We aimed to quantify the effects of immune checkpoint inhibitors (ICIs) on the prognosis
of COVID-19. Materials & methods: A meta-analysis was conducted and the hospitalization …
of COVID-19. Materials & methods: A meta-analysis was conducted and the hospitalization …
[HTML][HTML] Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era
G Arpino, C De Angelis, P De Placido, E Pietroluongo… - ESMO open, 2020 - Elsevier
Background Immunosuppression induced by anticancer therapy in a COVID-19-positive
asymptomatic patient with cancer may have a devastating effect and, eventually, be lethal …
asymptomatic patient with cancer may have a devastating effect and, eventually, be lethal …
“Swords and Shields” against COVID-19 for patients with cancer at “clean” and “pandemic” hospitals: are we ready for the second wave?
C Karacin, R Acar, O Bal, T Eren, MAN Sendur… - Supportive Care in …, 2021 - Springer
Purpose COVID-19 will continue to disrupt the diagnosis-treatment process of cancer
patients. Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital has been considered as a …
patients. Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital has been considered as a …